Printer Friendly

Browse Clinical trials topic

Subtopics (88)

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
An Overlooked Cancer Therapy and Clinical-Trial Opportunity. Faloon, William; Strum, Stephen Aug 13, 2022 2303
AstraZeneca granted US approval of Enhertu for HER2-mutant NSCLC. Aug 12, 2022 151
Pfizer reports positive top-line results from Phase 3 study of IPD vaccine candidate. Aug 12, 2022 234
Pfizer reports positive top-line results from Phase 3 study of IPD vaccine candidate. Aug 12, 2022 233
Nabriva Therapeutics completes patient enrollment in Phase 1 trial of XENLETA. Aug 11, 2022 156
Greenwich LifeSciences commences Phase III clincial trial of GLSI-100. Aug 11, 2022 181
Arbele doses first Australian patient in Phase I ARB202 Study. Aug 11, 2022 170
Arbele doses first Australian patient in Phase I ARB202 Study. Aug 11, 2022 169
Recbio declares completion of subject enrolment and first dose vaccination in phase III clinical trial of recombinant HPV 9-valent vaccine. Aug 10, 2022 208
Recbio declares completion of subject enrolment and first dose vaccination in phase III clinical trial of recombinant HPV 9-valent vaccine. Aug 10, 2022 209
LianBio completes enrollment in phase 3 EXPLORER-CN trial of mavacamten. Clinical report Aug 10, 2022 282
VYNE announces Phase 2a trial of FMX144 did not meet primary endpoint. Aug 10, 2022 233
First Patient Dosed in a Phase 1b Clinical Trial of UPB-101 in Asthma. Aug 10, 2022 350
Pfizer, Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15. Aug 10, 2022 427
Saol Therapeutics enrols first patient in SL-1002 phase two COMPASS Osteoarthritis Pain Trial. Clinical report Aug 10, 2022 191
Saol Therapeutics enrols first patient in SL-1002 phase two COMPASS Osteoarthritis Pain Trial. Clinical report Aug 10, 2022 190
Inmagene and HUTCHMED announce start of IMG-004 Phase I trial. Aug 9, 2022 163
Sapience Therapeutics conducts sub-study of ST101 Phase 1-2 clinical trial in recurrent and newly diagnosed GBM patients. Aug 9, 2022 222
Frontier Biotechnologies announces positive results from FB2001 Phase 1 clinical trial. Financial report Aug 9, 2022 179
Inmagene and HUTCHMED announce start of IMG-004 Phase I trial. Aug 9, 2022 164
Sapience Therapeutics conducts sub-study of ST101 Phase 1-2 clinical trial in recurrent and newly diagnosed GBM patients. Aug 9, 2022 223
Frontier Biotechnologies announces positive results from FB2001 Phase 1 clinical trial. Financial report Aug 9, 2022 180
Pfizer and Valneva launch Phase 3 trial of Lyme disease vaccine. Clinical report Aug 9, 2022 217
Xilio Therapeutics announces preliminary Phase 1 dose-escalation data for XTX101. Aug 9, 2022 261
Veru announces presentation of phase 3 study of Sabizabulin. Clinical report Aug 9, 2022 230
Pfizer and Valneva launch Phase 3 trial of Lyme disease vaccine. Clinical report Aug 9, 2022 216
Establishment Labs Completes Enrollment in Motiva US IDE Study. Clinical report Aug 8, 2022 382
BioNTech reports first-half growth; plans to start trial of Omicron-adapted vaccine. Aug 8, 2022 212
BioNTech reports first-half growth; plans to start trial of Omicron-adapted vaccine. Aug 8, 2022 213
AstraZeneca, Hutchmed report results from SAVANNAH Phase II trial. Aug 8, 2022 153
Zai Lab partner Karuna announces results from Phase 3 EMERGENT-2 trial. Financial report Aug 8, 2022 481
Cocrystal Pharma engages CRO to conduct Phase 1a trial with CC-42344. Aug 8, 2022 249
Vaccinex announces publication of results of Phase 2 SIGNAL study. Aug 8, 2022 544
Amgen says tarlatamab showed 'encouraging antitumor activity' in Phase 1 study. Aug 8, 2022 212
Pfizer, Valneva initiate Phase 3 study of Lyme disease vaccine candidate VLA15. Aug 8, 2022 184
Ascletis Pharma doses first patient in ASC61 US phase one clinical trial to treat advanced solid tumours. Aug 8, 2022 176
Kodiak Sciences completes enrolment of patients in GLOW Phase three tarcocimab tedromer clinical trial. Aug 8, 2022 193
Ascletis Pharma doses first patient in ASC61 US phase one clinical trial to treat advanced solid tumours. Aug 8, 2022 177
Kodiak Sciences completes enrolment of patients in GLOW Phase three tarcocimab tedromer clinical trial. Aug 8, 2022 194
The Value Of Clinical Trials In Drug Development. Aug 7, 2022 832
EQRx announces updated data from Phase 3 trial of Sugemalimab. Aug 7, 2022 197
Novavax starts Phase 2b/3 Hummingbird global clinical trial to assess Novavax COVID-19 vaccine in younger children. Aug 5, 2022 187
Novavax starts Phase 2b/3 Hummingbird global clinical trial to assess Novavax COVID-19 vaccine in younger children. Aug 5, 2022 188
Tarsus Pharmaceuticals initiates Phase 2a Eras trial evaluating TP-03. Aug 5, 2022 205
ImmunAbs Gains US FDA Approval for a Phase 1 Clinical Trial. Aug 5, 2022 324
UKGCC donates GH50,000 towards establishment of clinical trials unit at UGMC. Aug 5, 2022 654
BioCryst resumes enrollment in BCX9930 clinical program. Aug 4, 2022 183
Astria Therapeutics Initiates Phase 1a Trial of STAR-0215, a Monoclonal Antibody Inhibitor of Plasma Kallikrein for Treatment of Hereditary Angioedema. Aug 4, 2022 317
Kenya to participate in monkeypox vaccine clinical trials. Aug 4, 2022 524
Kenya to participate in monkeypox vaccine clinical trials. Aug 4, 2022 519
Jiangsu Recbio Technology announces Philippine approval of comparative study between ReCOV and mRNA vaccines. Aug 3, 2022 224
Ipsen: Phase III RESILIENT trial did not meet primary endpoint of OS. Aug 3, 2022 158
Landos Biopharma announces top-line results from NX-13 Phase 1b trial. Financial report Aug 3, 2022 172
Merrimack: Ipsen says primary endpoint not met in Phase 3 Onivyde trial. Aug 3, 2022 189
Cornerstone announces completion of Phase 1b trial of CPI-613. Aug 3, 2022 153
Athira Pharma presents data from ACT-AD Phase 2 proof-of-concept study. Aug 3, 2022 348
Context Therapeutics signs clinical trial collaboration and supply agreement with The Menarini Group. Aug 3, 2022 172
Jiangsu Recbio Technology announces Philippine approval of comparative study between ReCOV and mRNA vaccines. Aug 3, 2022 225
Context Therapeutics signs clinical trial collaboration and supply agreement with The Menarini Group. Aug 3, 2022 171
EyePoint Pharmaceuticals doses first patient in phase two 'Durasert and Vorolanib in Ophthalmology 2' EYP-1901 clinical trial. Aug 2, 2022 294
Tavanta Therapeutics completes patient enrolment for Phase three study of TAVT-45 Granules for Oral Suspension. Aug 2, 2022 172
EyePoint Pharmaceuticals doses first patient in phase two 'Durasert and Vorolanib in Ophthalmology 2' EYP-1901 clinical trial. Aug 2, 2022 295
Tavanta Therapeutics completes patient enrolment for Phase three study of TAVT-45 Granules for Oral Suspension. Aug 2, 2022 173
Context Therapeutics, The Menarini Group announce clinical trial collab. Aug 2, 2022 186
Context Therapeutics announces clinical trial collaboration with Menarini Group. Aug 2, 2022 186
Innovent Biologics and Laekna Therapeutics dose first patient in phase one/two clinical trial of three-drug combination therapy. Aug 1, 2022 237
Lynk Pharmaceuticals doses first participant in LNK01004 phase one clinical study in China. Clinical report Aug 1, 2022 170
Innovent Biologics and Laekna Therapeutics dose first patient in phase one/two clinical trial of three-drug combination therapy. Aug 1, 2022 236
Lynk Pharmaceuticals doses first participant in LNK01004 phase one clinical study in China. Clinical report Aug 1, 2022 169
Concert Pharma reports results for 2nd CTP-543 Phase 3 trial in Alopecia Areata. Financial report Aug 1, 2022 350
Otonomy reports results from Phase 2 trial of OTO-313. Aug 1, 2022 264
Verrica Pharmaceuticals announces start of Phase 3 trial of VP-102. Aug 1, 2022 205
Evofem completes last subject last visit in Phase 3 trial of Phexxi. Aug 1, 2022 152
SciSparc signs clinical trial agreement with Yale University. Aug 1, 2022 307
Krystal Biotech announces FDA accepted IND application for KB407. Aug 1, 2022 163
NewAmsterdam Pharma Doses First Patient in Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia. Aug 1, 2022 619
First Patient Dosed in a Phase 1 Trial Evaluating a Novel Off-the-Shelf Engineered Natural Killer Cellular Therapy for the Treatment of Non-Small Cell Lung Cancer. Aug 1, 2022 451
SENSORION INITIATES PROOF OF CONCEPT CLINICAL TRIAL. Jul 30, 2022 523
INITIAL IND APPLICATION FOR ASIDNA GRANTED. Jul 30, 2022 453
Brit, 39, who flew to US for cancer treatment dies in Texas after it failed to work; Cormac McLaughlin, from Co. Tyrone, passed away after flying to Texas for a clinical trial when he found out he was diagnosed with an aggressive brain tumour. By, Sean McPolin Obituary Jul 30, 2022 437
Clinical Efficacy of PD-1 Inhibitors Plus Split-Course Radiotherapy in the First-Line Treatment of Advanced Kidney Cancer: A Randomized Controlled Trial. Li, Weiping; Cao, Zhigang; Chang, Pengcheng; Zhang, Bin; Li, Fudong; Chang, Dehui Jul 30, 2022 4058
Sound Pharmaceuticals enrols first patient in SPI-1005 Phase three clinical trial. Jul 29, 2022 165
Sound Pharmaceuticals enrols first patient in SPI-1005 Phase three clinical trial. Jul 29, 2022 166
Enanta Pharmaceuticals Touts Positive Data from a Phase 1 Clinical Study of EDP-235, its Oral 3CL Protease Inhibitor Designed for the Treatment of COVID-19. Jul 29, 2022 625
MyMD Pharmaceuticals Advances Phase 2 Multi-Center Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan. Jul 28, 2022 216
Valbiotis completes recruitment for Phase II/III clinical study with TOTUM-63. Clinical report Jul 28, 2022 159
Valbiotis completes recruitment for Phase II/III clinical study with TOTUM-63. Clinical report Jul 28, 2022 160
ViiV Healthcare announces data from unblinded phase of HPTN 084 study. Jul 28, 2022 492
Drug may slow disease; TEEN ALEX TAKING PART IN TRIALS OF TREATMENT. STAFF REPORTER Jul 27, 2022 327
Biomica doses first patient in BMC128 phase one clinical trial. Jul 27, 2022 207
Biomica doses first patient in BMC128 phase one clinical trial. Jul 27, 2022 206
Cortexyme Completes Phase 1 Single and Multiple Ascending Dose Clinical Trial of COR588. Jul 27, 2022 380
ADC Therapeutics Doses First Patient in Phase 1b Clinical Trial of ADCT-601 Targeting AXL as a Single Agent and in Combination with Gemcitabine in Advanced Solid Tumors. Jul 27, 2022 382
Ideaya Biosciences, Amgen enter IDE397 clinical trial collaboration. Jul 27, 2022 236
Celularity announces treatment of first patient in Phase 1/2a trial of CYNK-101. Jul 27, 2022 190
180 Life Sciences says University of Oxford awarded grant for clinical trial. Jul 27, 2022 210
Sling Therapeutics starts enrolment in global Phase 2b LIDS clinical trial of linsitinib. Jul 26, 2022 188
Sling Therapeutics starts enrolment in global Phase 2b LIDS clinical trial of linsitinib. Jul 26, 2022 187
Seagen and Astellas report positive topline results from phase 1b/2 EV-103 clinical trial of PADCEV combined with Merck's KEYTRUDA to treat advanced urouthelial cancer. Jul 26, 2022 355
Seagen and Astellas report positive topline results from phase 1b/2 EV-103 clinical trial of PADCEV combined with Merck's KEYTRUDA to treat advanced urouthelial cancer. Jul 26, 2022 356
Immuron reports feedback from FDA regarding IND targeting Campylobacter and ETEC. Jul 26, 2022 167
Clearside Biomedical completes dosing in OASIS Phase 1/2a trial of CLS-AX. Jul 26, 2022 247
Diffusion Pharmaceuticals to initiate Phase 2 trial in patients with GBM. Jul 26, 2022 375
BridgeBio announces interim results from Phase 2 trial of infigratinib. Jul 26, 2022 597
Neovasc announces FDA approval of protocol supplement to COSIRA-II trial. Jul 26, 2022 394
GenFleet Therapeutics' GFH018 clinical trial applications receive Chinese regulatory approval. Jul 25, 2022 232
I-Mab doses first patient in TJ-CD4B Phase clinical trial for patients with solid tumours. Drug overview Jul 25, 2022 252
GenFleet Therapeutics' GFH018 clinical trial applications receive Chinese regulatory approval. Jul 25, 2022 233
I-Mab doses first patient in TJ-CD4B Phase clinical trial for patients with solid tumours. Drug overview Jul 25, 2022 253
AstraZeneca's Tezspire recommended for EU approval for treatment of severe asthma. Jul 25, 2022 202
AstraZeneca's Tezspire recommended for EU approval for treatment of severe asthma. Jul 25, 2022 201
AstraZeneca's Tezspire recommended for EU approval for treatment of severe asthma. Jul 25, 2022 200
AstraZeneca's Tezspire recommended for approval in E.U. by CHMP in severe asthma. Jul 25, 2022 176
Sonnet BioTherapeutics announces Phase 1b/2a trial of SON-080 in CIPN. Jul 22, 2022 317
First Patient Enrolled in a Phase 2 Trial of NTX-001 for the Prevention of Facial Paralysis and Provides Update on the Phase 2 Study of NTX-001 in Peripheral Nerve Injuries due to Trauma. Clinical report Jul 22, 2022 160
Bristol Myers Squibb Launches Disability Diversity in Clinical Trials Initiative to Improve Healthcare Outcomes for People with Disabilities. Jul 22, 2022 454
LB Announces Publication of Phase 1 Clinical Study of LB-102. Jul 22, 2022 319
Yuyu Pharma enrols first patient in YP-P10 phase two clinical study. Jul 21, 2022 166
Yuyu Pharma enrols first patient in YP-P10 phase two clinical study. Jul 21, 2022 167
Rheos Medicines Receives FDA "Study May Proceed" Letter to Initiate Phase 1 Clinical Study of RHX-317 for Treatment of Autoimmune and Inflammatory Diseases. Jul 21, 2022 346
First Patient Dosed in Phase 2 Clinical Trial of Zynlonta in Combination with Rituximab in First-Line Diffuse Large B-Cell Lymphoma. Jul 21, 2022 485
First Patient Dosed in Phase I Clinical Trial of ITI-3000 pDNA Vaccine for the Treatment of Merkel Cell Carcinoma. Jul 21, 2022 358
Skye Bioscience selects NextPharma as Phase 2 contract drug manufacturer. Jul 21, 2022 192
Olema Oncology receives FDA fast track designation for OP-1250. Jul 21, 2022 181
Field Trip Health announces first dosings in Phase 1 clinical study of FT-104. Jul 21, 2022 275
Celldex announces first patient dosed in Phase 2 study of barzolvolimab. Clinical report Jul 21, 2022 213
PharmaCyte Biotech starts 1st phase of two-phase pig study. Jul 21, 2022 196
Dice completes enrollment in study of oral IL-17 antagonist, DC-806. Clinical report Jul 21, 2022 200
Takeda Touts Positive Topline Results from Pivotal Phase 3 Clinical Trial Evaluating Hyqvia for Maintenance Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP). Jul 21, 2022 626
PharmaCyte Biotech Commences First Phase of Two-Phase Pig Study. Jul 21, 2022 346
Clinical Study on Prevention of Irinotecan-Induced Delayed-Onset Diarrhea by Hot Ironing with Moxa Salt Packet on Tianshu and Shangjuxu. Lai, Xianghong; Wang, Anmei Clinical report Jul 21, 2022 5172
VBL Therapeutics Phase 3 ovarian cancer trial misses primary endpoints. Jul 20, 2022 232
Skye Bioscience updates Phase 1 timeline. Chronology Jul 20, 2022 268
Adial Pharmaceuticals announces results for Onward Phase 3 trial for Ad04. Jul 20, 2022 398
Labcorp Expands Automated Clinical Trial Kit Production Line at European Operations Center. Jul 20, 2022 300
Arbutus Biopharma plans to continue dosing in triple combination clinical trial. Jul 20, 2022 171
ProtoKinetix Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants. Jul 20, 2022 165
KGK Science Inks Research Contract with Halucenex for Phase II Clinical Trial. Jul 20, 2022 399
Guided Therapeutics Receives Institutional Review Board Approval to Start Clinical Study for FDA Approval of the LuViva Advanced Cervical Scan. Jul 20, 2022 324
First Patient Dosed in CANbridge Pharmaceuticals CAN103 Phase 1/2 Trial for the Treatment of Gaucher Disease in China. Jul 20, 2022 659
Patient Dosing Starts in CARDINAL-HF, a Phase 2 Clinical Trial of Cardurion Pharmaceuticals' PDE9 inhibitor in Heart Failure. Jul 19, 2022 558
Viking Therapeutics: FDA lifts clinical hold on Phase 1b trial of VK0214. Jul 19, 2022 192
Artelo Biosciences completes enrollment of first three cohorts in CAReS study. Clinical report Jul 19, 2022 226
Capricor announces first patient dosed in Phase 3 study of CAP-1002. Clinical report Jul 19, 2022 191
Sinovac Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile. Jul 19, 2022 363
Merck to stop Phase 3 LYNK-003 trial investigating LYNPARZA. Jul 18, 2022 189
Post-Hoc Analysis from GATHER1 Clinical Trial of Zimura Presented at American Society of Retina Specialists Meeting. Jul 18, 2022 492
Bangavax gets DGDA nod for clinical trial. Jul 18, 2022 437
EyePoint Pharmaceuticals reveals 12-month data from Phase 1 'Durasert and Vorolanib in Ophthalmology' (DAVIO) clinical trial assessing EYP-1901. Jul 18, 2022 384
Escend Pharmaceuticals' ES-3000 investigational new drug application receives US FDA approval. Jul 18, 2022 164
EyePoint Pharmaceuticals reveals 12-month data from Phase 1 'Durasert and Vorolanib in Ophthalmology' (DAVIO) clinical trial assessing EYP-1901. Jul 18, 2022 383
Escend Pharmaceuticals' ES-3000 investigational new drug application receives US FDA approval. Jul 18, 2022 163
Therapeutic Solutions International Granted Emergency IND by FDA for Expanded Patient Access to JadiCell Universal Donor Stem Cell for COVID-19 ARDS Outside of Ongoing Phase III Clinical Trial. Jul 18, 2022 179
The Lancet Oncology Publishes Data from Phase 1b Clinical Study of Zandelisib in Patients with Relapsed or Refractory B-cell Malignancy. Jul 18, 2022 910
Grail and National Health Service England Complete Enrollment of 140,000 Participants in Largest Study of Multi-Cancer Early Detection Test. Jul 18, 2022 653
Efficacy and Safety of Apatinib plus Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cancer: A Phase II Trial. Yang, Bo; Guo, Xiaofeng; Le, Cheng; Su, Wenzhong; Li, Xiaoming; Zhang, Yanfeng; Yang, Guangyi; Liang Report Jul 18, 2022 4359
Bridging Experience and Expertise: A Case Study of COVID-19 Vaccine Trial Participation and Social Media Vaccine Communication. Campeau, Kari Case study Jul 17, 2022 9664
DGDA approves Bangavax for clinical trial in 1st phase. Jul 17, 2022 315
Rishi Sunak targets scrapping EU laws in fresh pitch to Brexiteers; Former chancellor indicated he would overhaul data protection rules and speed up clinical trials. By, Gavin Cordon, PA Whitehall Editor & Shane Jarvis Jul 17, 2022 592
Omega Therapeutics' OTX-2002 Investigational New Drug application receives US FDA approval to start phase one/two, first-in-human, clinical study. Jul 15, 2022 200
Omega Therapeutics' OTX-2002 Investigational New Drug application receives US FDA approval to start phase one/two, first-in-human, clinical study. Jul 15, 2022 199
HUTCHMED doses first patient in Phase I trial of HMPL-A83 in China. Jul 15, 2022 167
HUTCHMED doses first patient in Phase I trial of HMPL-A83 in China. Jul 15, 2022 166
First Patient Dosed in Phase 1 Study for BAT8006, an Antibody Drug Conjugate Targeting Folate Receptor I[+ or -] for the Treatment of Advanced Solid Tumors. Jul 15, 2022 447
EyePoint reports 'positive' 12-month data from Phase 1 trial of EYP-1901. Jul 15, 2022 312
Endevica Bio Doses First Patient in Phase 1 Clinical Trial of TCMCB07 for the Treatment of Cachexia. Jul 15, 2022 363
Efficacy of High-Dose Vitamin C Infusion on Outcomes in Sepsis Requiring Mechanical Ventilation: A Double-Blind Randomized Controlled Trial. El Driny, Wessam A.; Esmat, Ibrahim M.; Shaheen, Sara M.; Sabri, Nagwa A. Jul 15, 2022 7394
Phase 3 Study Results in People with COVID-19 Shows SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days. Jul 14, 2022 730
Summit Therapeutics plans to explore additional clinical trial for ridinilazole. Jul 14, 2022 174
Revelation Biosciences completes data base lock for its Phase 1b CLEAR study. Jul 14, 2022 181
ABVC BioPharma provides ADHD Phase II Part 2 clinical update. Clinical report Jul 13, 2022 156
Novan announces publication of 'positive' Phase 3 results in JAMA Dermatology. Clinical report Jul 13, 2022 249
Tetra Therapeutics Initiates Phase 2b/3 Clinical Studies of Investigational Drug BPN14770 in Fragile X Syndrome. Clinical report Jul 13, 2022 473
Aculys Pharma and Susmed Ink Contract to Conduct the World's First Clinical Trial Utilizing Blockchain Technology. Jul 13, 2022 692
No adverse events at COVID vaccine trials so far: Bio Farma. Jul 13, 2022 320
Phase 3 trial of Merah Putih vaccine on in Padang Pariaman. Jul 13, 2022 361
Rhythm announces interim results from Phase 2 trial of setmelanotide. Jul 12, 2022 268
Aldeyra: Primary endpoints in DED chamber crossover clinical trial achieved. Jul 12, 2022 321
Dyne announces clearance of clinical trial application for DYNE-101. Jul 12, 2022 199
Cybin begins trial enrollment for CYB003 study for MDD treatment. Jul 12, 2022 210
Y-mAbs Therapeutics announces clearance of IND for GD2-SADA. Jul 12, 2022 216
Apyx Medical Posts Results of the US IDE Clinical Study Evaluating the Use of Renuvion to Improve the Appearance of Lax Skin in the Neck and Submental Region. Clinical report Jul 12, 2022 263
Surgical Parameters Related to Excessive Intrarenal Pressure during Minimally Invasive Percutaneous Nephrolithotomy in the Supine Position: A Prospective Observational Clinical Study. Jung, Gyoohwan; Kho, Yongseok; Park, Jae Suk; Yuk, Hyeong Dong; Ryang, Seung Hoon; Cho, Sung Yong Report Jul 12, 2022 4871
First Patient Dosed in China with Zylonta, Rituximab Combination in Global Phase 3 Clinical Trial. Jul 11, 2022 552
Evogene announces enrollment of first patient in Phase I study of BMC128. Jul 11, 2022 199
Iterum announces SPA agreement with FDA on Phase 3 trial of oral sulopenem. Jul 11, 2022 216
Aethlon announces US FDA approval of Hemopurifier study protocol amendment. Jul 11, 2022 226
Cybin Closes CDN 1m Acquisition of DMT Clinical Study. Clinical report Jul 11, 2022 207
Cybin Closes CDN 1m Acquisition of DMT Clinical Study. Clinical report Jul 11, 2022 183
Freeline presents data from first cohort of Phase 1/2 dose-confirmation B-LIEVE. Jul 10, 2022 279
Pliant announces safety, efficacy data from Phase 2a INTEGRIS-IPF trial. Clinical report Jul 10, 2022 235
Improvements of Physical Activity Performance and Motivation in Adult Men through Augmented Reality Approach: A Randomized Controlled Trial. Nekar, Daekook M.; Kang, Hye Yun; Yu, Jae Ho Clinical report Jul 9, 2022 8279
Efficacy and Safety of Tripterygium Wilfordii Glycoside Tablets Combined with Acitretin Capsules in the Treatment of Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial. Fu, Qinghui; Zhu, Yunjie; Fang, Yiqi; Dai, Changbo Jul 9, 2022 4324
Sublingual Sufentanil vs. Intravenous Fentanyl for the Treatment of Acute Postoperative Pain in the Ambulatory Surgery Center: A Randomized Clinical Trial. Berg, Aaron; Habeck, Jason; Strigenz, Michael; Pearson, Jonah; Kaizer, Alexander; Hutchins, Jacob Clinical report Jul 8, 2022 4094
Prevention of Postoperative Events following Reversal with Sugammadex or Neostigmine (the P-PERSoN Trial): Pilot Data Following Early Termination of a Prospective, Blinded, Randomised Trial. Olesnicky, Benjamin; Doane, Matthew; Farrell, Clare; Knoblanche, Greg; Delaney, Anthony Jul 8, 2022 4428
Smartphone Application for Celiac Patients: Assessing Its Effect on Gastrointestinal Symptoms in a Randomized Controlled Clinical Trial. Nikniaz, Zeinab; Namvar, Zahra Akbari; Shirmohammadi, Masood; Maserat, Elham Clinical report Jul 8, 2022 4943
InnoCare Receives China Approval of Clinical Trial of Novel Targeted Protein Degrader ICP-490. Jul 8, 2022 309
Dosing Begins in Filament Health Psilocin Clinical Trial. Jul 8, 2022 266
Burke Neurological Institute Receives a USD 45m NIH Grant to Study a Vitamin B1 Precursor for Treatment of Alzheimer's Disease in Multi-center Clinical Trial. Jul 8, 2022 721
Lysogene Provides Additional Update on AAVance Phase 2/3 Gene Therapy Clinical Trial with LYS-SAF302 in children with MPS IIIA. Jul 8, 2022 789
MediWound's EscharEx shows positive Phase 2 results in leg ulcers. Clinical report Jul 7, 2022 152
Amryt Pharma presents new Phase 3 trial analyses in DEB. Jul 7, 2022 152
Biohaven enrolls first patient in Phase 3 trial of taldefgrobep alfa. Jul 7, 2022 182
Annovis Bio announces positive FDA notice for buntanetap Phase 3 trial. Jul 7, 2022 156
Akari Therapeutics reports first completed treatment in Phase 3 nomacopan trial. Jul 7, 2022 199
Miracle treatment changed one man's life in lockdown trial -after IBS had 'brought life to a standstill'; Anthony Anderson has spoken of how a new IBS treatment changed his life. By, Sam Volpe Jul 7, 2022 781
PS50K COULD GIVE TERMINALLY ILL SARAH HER LIFE McCrimmon BACK; FUNDRAISER LAUNCHED FOR NHS WORKER Nurse, 23, with a rare kidney cancer pins hopes on clinical trial in America. CALAM PENGILLY Jul 7, 2022 560
Alterity Therapeutics doses first patient in phase two clinical trial of ATH434 in Multiple System Atrophy. Jul 7, 2022 193
Alterity Therapeutics doses first patient in phase two clinical trial of ATH434 in Multiple System Atrophy. Jul 7, 2022 194
Common brain supplement could spur on Alzheimer's, study warns; Recent clinical research into dementia has unexpectedly found that one common chemical in brain-boosting supplements can actually lead to the onset of the degenerative brain disease, rather than counter it. By, William Morgan Clinical report Jul 6, 2022 403
Inmagene and HUTCHMED report dosing of first participant in global Phase I trial of investigational OX40 antagonistic monoclonal antibody IMG-007. Jul 6, 2022 181
Inmagene and HUTCHMED report dosing of first participant in global Phase I trial of investigational OX40 antagonistic monoclonal antibody IMG-007. Jul 6, 2022 180
Innocoll Highlights Publication of Positive Results from Pivotal Clinical Trial of Posimir in Arthroscopic Subacromial Decompression. Jul 6, 2022 493
Bruker Launches NMR-based Molecular Phenomics Clinical Research Tool for 'Long COVID' Multi-Organ Risk Assessment. Jul 6, 2022 395
Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine. Sharma, Ashwani; Virmani, Tarun; Pathak, Vipluv; Sharma, Anjali; Pathak, Kamla; Kumar, Girish; Patha Report Jul 6, 2022 12684
Arctic Vision enrols first patient in ARVN003 phase III clinical study. Clinical report Jul 5, 2022 180
JW Therapeutics commences phase one clinical study of JWATM204 in advanced hepatocellular carcinoma patients. Clinical report Jul 5, 2022 181
Abbisko Therapeutics doses first patient in ABSK061 Phase one clinical trial. Jul 5, 2022 169
Arctic Vision enrols first patient in ARVN003 phase III clinical study. Clinical report Jul 5, 2022 179
JW Therapeutics commences phase one clinical study of JWATM204 in advanced hepatocellular carcinoma patients. Clinical report Jul 5, 2022 180
Abbisko Therapeutics doses first patient in ABSK061 Phase one clinical trial. Jul 5, 2022 168
Orexo initiates human clinical study of nasal adrenaline rescue medication OX640. Report Jul 5, 2022 154
Orexo initiates human clinical study of nasal adrenaline rescue medication OX640. Report Jul 5, 2022 152
Anebulo Pharmaceuticals reports ANEB-001's positive topline data in Phase 2 clinical trial for acute cannabinoid intoxication. Jul 5, 2022 320
Orexo initiates human clinical study of nasal adrenaline rescue medication OX640. Report Jul 5, 2022 153
Anebulo Pharmaceuticals reports ANEB-001's positive topline data in Phase 2 clinical trial for acute cannabinoid intoxication. Jul 5, 2022 321
Anebulo says Phase 2 ANEB-001 clinical trial met primary endpoint. Jul 5, 2022 494
Nevro announces 12-month results from SENZA-PDN randomized controlled trial. Financial report Jul 5, 2022 269
Fulcrum announces dosing of first patient in Phase 3 trial of losmapimod. Jul 5, 2022 267
Ayala announces interim results from Phase 2/3 clinical trial evaluating AL102. Jul 5, 2022 252
US FDA Lifts Clinical Hold on VX-880 Phase 1/2 Clinical Trial for the Treatment of Type 1 Diabetes. Jul 5, 2022 397
Arrowhead Pharmaceuticals Initiates Phase 1/2a Studies for Two Pulmonary Candidates ARO-MUC5AC and ARO-RAGE. Jul 5, 2022 339
Anebulo Pharmaceuticals Touts Positive Topline Data for ANEB-001 from a Phase 2 Clinical Trial for Acute Cannabinoid Intoxication. Jul 5, 2022 549
Pre-clinical trial of Merah Putih Vaccine to commence July-end 2022. Jul 5, 2022 316
Pre-clinical trial of Merah Putih Vaccine to commence July-end 2022. Jul 5, 2022 313
Innovent Biologics doses first ulcerative colitis patient in phase two clinical study of IBI112 in China. Clinical report Jul 4, 2022 187
Abbisko Therapeutics completes dosing of first patient in Phase 1 clinical trial in advanced solid tumours for ABSK061. Jul 4, 2022 160
Innovent Biologics doses first ulcerative colitis patient in phase two clinical study of IBI112 in China. Clinical report Jul 4, 2022 186
Abbisko Therapeutics completes dosing of first patient in Phase 1 clinical trial in advanced solid tumours for ABSK061. Jul 4, 2022 159
Roche eyes clinical trials in PH. Jul 4, 2022 679
SINOVAC joins hands with HKU-CTC research team and Gleneagles Hospital Hong Kong to kick off a clinical trial of an Omicron-specific inactivated vaccine for booster use in Hong Kong, China. Jul 4, 2022 663
Receptor Life Sciences Announces First Patient Dosed with RLS103 in Phase 1b/2a Clinical Study in Acute Anxiety within Social Anxiety Disorder. Jul 1, 2022 294
MTTI Doses First Patient in EBTATE Neuroendocrine Tumor Clinical Trial. Jul 1, 2022 177
Axalbion Touts Positive Findings from Phase 2 Clinical Study in Chronic Cough with Novel TRPM8 Agonist. Clinical report Jul 1, 2022 616
ADC Therapeutics Doses First Patient in Phase 1b Clinical Trial of Zylonta in Combination with Other Anti-cancer Agents. Jul 1, 2022 540
Phase I of the DiaVACCS screening trial: Study design, methods, population demographics and baseline results. Dreyer, G.; Snyman, L.C.; van der Merwe, F.H.; Richter, K.L.; Dreyer, G.J.; Visser, C.; Botha, M.H. Report Jul 1, 2022 7588
A clinical study on latest trends of psoriasis in patients attending dermatology OPD in a tertiary care center. Darsan S, Suruthi Purushothaman, Budeda Hasini, S.S Ravi and V.V.V. Satyanarayana Clinical report Jun 30, 2022 1184
CanariaBio reaches 50% target enrolment for Phase III clinical study of oregovomab to treat front-line advanced ovarian cancer. Clinical report Jun 30, 2022 276
CanariaBio reaches 50% target enrolment for Phase III clinical study of oregovomab to treat front-line advanced ovarian cancer. Clinical report Jun 30, 2022 275
Sanofi reports patient enrollment of phase 3 tolebrutinib trials paused in U.S. Jun 30, 2022 268
Cara Therapeutics announces results from Phase 2 trial of difelikefalin. Jun 30, 2022 281
BioRestorative announces first patient enrolled in Phase 2 trial of BRTX-100. Clinical report Jun 30, 2022 188
Aura Biosciences Receives FDA Fast Track Designation for Belzupacap Sarotalocan for the Treatment of Non-Muscle Invasive Bladder Cancer. Jun 30, 2022 215
PureTech Initiates Late-Stage Clinical Study of Wholly-Owned Candidate LYT-100 in IPF and Advances LYT-200. Clinical report Jun 30, 2022 556
Celldex presents positive Phase 1b interim data from barzolvolimab. Jun 30, 2022 156
Improvement of fertility outcomes using dexamethasone / antibiotic adjuvant therapy following hysterosalpingography in infertile females: A randomised trial. El-Kharoubi Amin-Florin and Szasz Florin Jun 30, 2022 2991
Protocol of Pakistan randomized and observational trial to evaluate coronavirus treatment among newly diagnosed patients with COVID-19: Azithromycin, Oseltamivir, and Hydroxychloquine. Shehnoor Azhar, Javed Akram, Muhammad Shahzad, Waqas Latif and Khalid Saeed Khan Jun 30, 2022 4906
The red flag bowel cancer symptoms that Deborah James wanted to highlight as part of lasting legacy; Deborah's Bowelbabe fund has now raised more than £6.8m for clinical trials and personalised medicine for cancer patients. By, Cathy Owen & Mark Smith Jun 29, 2022 1352
Soligenix's SGX302 IND clinical trial application receives US FDA approval. Jun 29, 2022 200
Soligenix's SGX302 IND clinical trial application receives US FDA approval. Jun 29, 2022 199
Aileron Therapeutics reports Phase 1b data of lung cancer candidate ALRN-6924. Jun 29, 2022 302
Agenus announces expanded data from Phase 1b study of botensilimab, balstilimab. Jun 29, 2022 219
AN2 Therapeutics initiates Phase 2/3 trial evaluating epetraborole. Jun 29, 2022 186
Galera Therapeutics announces results from Phase 1 stage of GRECO-1 trial. Financial report Jun 29, 2022 317
Trevi Therapeutics' Haduvio meets efficacy endpoint in Phase 2b/3 trial. Jun 29, 2022 217
Global Blood Therapeutics initiates Phase 2/3 clinical trial of GBT601. Jun 29, 2022 203
Codiak initiates patient dosing in Phase 1 trial of exoASO-STAT6. Jun 29, 2022 184
Advaxis announces an update on Phase 1 trial of ADXS-504. Jun 29, 2022 250
US FDA Approves Prestige Biopharma's IND for Phase 1/2a Trial of First-in-Class Pancreatic Cancer Treatment, PBP1510. Jun 29, 2022 415
Xingnao Kaiqiao Acupuncture Method Combined with Temporal Three-Needle in the Treatment of Acute Ischemic Stroke: A Randomized Controlled Trial. Song, Zhongtao; Huang, Qingyuan; Guo, Yuxia; Song, Xiaodong; Zhang, Xuan; Xiao, Huajun Jun 29, 2022 5374
Phase 3 of Merah Putih clinical trial begins. Jun 28, 2022 405
Ceruvia Lifesciences' synthetic psilocybin Phase two clinical trial receives US FDA approval. Jun 28, 2022 200
Ceruvia Lifesciences' synthetic psilocybin Phase two clinical trial receives US FDA approval. Jun 28, 2022 199
Decibel reports data from interim analysis of Phase 1b trial of DB-020. Jun 28, 2022 315
Schrodinger gets FDA clear for IND application or MALT1 inhibitor, SGR-1505. Jun 28, 2022 259
Revolution Medicines doses first patient in Phase 1/1b trial of RMC-6236. Jun 28, 2022 198
MeiraGTx announces data from the MGT009 Phase 1/2 clinical study. Clinical report Jun 28, 2022 263
Icosavax plans to file IND submission and initiate a Phase 1 trial for IVX-A1. Jun 28, 2022 209
Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder. Jun 28, 2022 377
Daewoong Pharmaceutical's IND for DWN12088 receives FDA approval for phase two clinical trial. Jun 27, 2022 192
Daewoong Pharmaceutical's IND for DWN12088 receives FDA approval for phase two clinical trial. Jun 27, 2022 193
Astellas Pharma says FDA places clinical hold on FORTIS Phase 1/2 trial. Jun 27, 2022 243
Takeda, Arrowhead announce results from Phase 2 study of fazirsiran. Clinical report Jun 27, 2022 279
AstraZeneca's Lynparza recommended for E.U. approval by CHMP in breast cancer. Jun 27, 2022 178
Tonix Pharmaceuticals announces trial design of new TNX-1300 Phase 2 study. Clinical report Jun 27, 2022 368
Cybin receives FDA IND clearance for Phase 1/2a trial evaluating CYB003. Jun 27, 2022 166
Otsuka, Lundbeck announce results from Phase 3 trial of brexpiprazole. Jun 27, 2022 153
Sellas Life Sciences provides clinical update for GFH009 ongoing Phase 1 trial. Jun 27, 2022 257
Acer Therapeutics announces initiation of phase 3 trial of EDSIVO in vEDS. Jun 27, 2022 182
Adial Pharmaceuticals announces database lock for ONWARD Phase 3 trial. Jun 27, 2022 294
Kezar Life Sciences announces positive phase 2 results from Zetomipzomib trial. Jun 27, 2022 214
Immunocore announces initial data from Phase 1 ImmTAV trial. Jun 26, 2022 340
Vir Biotechnology announces new clinical data from broad Hepatitis B program. Jun 26, 2022 443
Covid vaccines saved 20 million lives in year -but slow rollout saw 600k die; Almost two-thirds of the world's population has now received at least one dose since the first Covid-19vaccine was administered outside of a clinical trial. By, Danny Halpin & Adam May Jun 26, 2022 1032
Ionis announces presentation of Phase 2b data for chronic hepatitis B treatment. Jun 25, 2022 322
Revive Therapeutics provides update on Phase 3 trial for bucillamine in COVID-19. Jun 24, 2022 203
Targovax announces that the FDA has granted authorization to initiate clinical trials with the enhanced TG01 RAS vaccine in the USA. Jun 24, 2022 235
Lifecare has initiated clinical studies of the smallest glucose sensor in the world for people diagnosed with diabetes. Jun 24, 2022 1266
Galderma Touts Positive Data from Phase III Trial, Demonstrating Efficacy and Safety of nemolizumab in Patients with Prurigo Nodularis. Jun 23, 2022 189
First Patient Dosed in Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 in China. Jun 23, 2022 194

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |